CAPPED BONUSZERTIFIKAT - MERCK & CO. Stock

Certificat

DE000PC1UZU9

Market Closed - Boerse Frankfurt Warrants 03:40:19 2024-06-07 pm EDT
104.4 EUR +0.74% Intraday chart for CAPPED BONUSZERTIFIKAT - MERCK & CO.
Current month+1.42%
1 month+0.41%
Date Price Change
24-06-07 104.4 +0.78%
24-06-06 103.6 +0.04%
24-06-05 103.6 +0.29%
24-06-04 103.3 +0.32%
24-06-03 103 -0.02%

Real-time Boerse Frankfurt Warrants

Last update June 07, 2024 at 03:40 pm EDT

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC1UZU
ISINDE000PC1UZU9
Date issued 2023-12-13
Strike 120 $
Maturity 2025-06-20 (378 Days)
Parity 1 : 1
Emission price 92.39
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 104.4
Lowest since issue 94.16
Spread 0.02
Spread %0.02%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.7 USD
Average target price
142.7 USD
Spread / Average Target
+9.19%
Consensus